Corrigendum to “Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats” [Int. Immunopharmacol. 15(3) (2013) 524–531, (S1567576913000507), (10.1016/j.intimp.2013.02.008)];Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats

International Immunopharmacology

Volumn 15, Issue 3, 2013, Pages 524-531

  Xing, Jianfeng ^a   You, Cuiyu ^a   Dong, Kai ^a   Sun, Jinyao ^b   You, Haisheng ^b   Dong, Yalin ^b   Sun, Jianning ^c  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

2,4,6 Trinitrobenzenesulfonic acid; 3,4 Oxo isopropylidene shikimic acid; Inflammatory bowel disease; Nuclear factor kappa B; Oxidative stress

Indexed keywords

3,4 OXO ISOPROPYLIDENE SHIKIMIC ACID; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; PROSTAGLANDIN E2; SHIKIMIC ACID DERIVATIVE; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; COLITIS; COLON INJURY; COLON MUCOSAL DAMAGE INDEX; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MUCOSAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RATING SCALE;

EID: 84874629736     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2023.109700     Document Type: Erratum

References (32)

1. G. Monteleone, F. Pallone, and T.T. Macdonald Emerging immunological targets in inflammatory bowel disease Curr Opin Pharmacol 11 2011 640 645
2. M.B. Grisham, and T. Yamada Neutrophils, nitrogen oxides, and inflammatory bowel disease Ann N Y Acad Sci 664 1992 103 115
3. D.S. Barbosa, R. Cecchini, M.Z. El Kadri, M.A. Rodriguez, R.C. Burini, and I. Dichi Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids Nutrition 19 2003 837 842
4. G. Sener, H. Aksoy, O. Sehirli, M. Yuksel, C. Aral, and N. Gedik Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities Dig Dis Sci 52 2007 2122 2132
5. L.J. Brasil, B. San-Miguel, N.A. Kretzmann, J.L. Amaral, C.G. Zettler, and N. Marroni Halothane induces oxidative stress and NF-kappaB activation in rat liver: protective effect of propofol Toxicology 227 2006 53 61
6. V. Garcia-Mediavilla, I. Crespo, P.S. Collado, A. Esteller, S. Sanchez-Campos, and M.J. Tunon The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells Eur J Pharmacol 557 2007 221 229
7. H.T. Wang, H.T. Jin, J.N. Sun, and Y.J. Guo Experimental studies on the antithrombosis effect of 3,4-oxo-isopropylidene-shikimic acid Acta Pharmacol Sin 37 2002 245 248
8. J.F. Xing, J.N. Sun, J.Y. Hou, Y.J. Guo, X.K. Wang, and X.H. Zheng Study on anti-inflammatory effects of 3,4-oxo-isopropylidene-shikimic acid Chin Pharm J 41 2006 1861 1863
9. W.Y. Sun, J.N. Sun, Q.P. Xu, and Y.J. Guo Effect of 3,4-oxo- isopropylidene-shikimic acid on free radical metabolism in the brain issue of rats subjected to middle cerebral artery thrombosis Chin Pharm J 18 2002 569 571
10. Y. Ma, J.N. Sun, Q.P. Xu, and Y.J. Guo Antagonizing effect of ISA on lipid peroxidation of vein endothelial cells J Beijing Univ TCM 30 2007 98 104
11. J.F. Xing, J.N. Sun, J.Y. Sun, C.Y. You, K. Dong, and J. Lv Protective effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis induced by trinitrobenzenesulfonic acid in rats Dig Dis Sci 57 2012 2045 2054
12. W.P. Wang, X. Guo, M.W. Koo, B.C. Wong, S.K. Lam, and Y.N. Ye Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats Am J Physiol Gastrointest 281 2001 586 594
13. I. Tsune, K. Ikejima, M. Hirose, M. Yoshikawa, N. Enomoto, and Y. Takei Dietary glycine prevents chemical-induced experimental colitis in the rat Gastroenterology 125 2003 775 785
14. C. Bobin-Dubigeon, X. Collin, N. Grimaud, J.M. Robert, G. Le Baut, and J.Y. Petit Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis Eur J Pharmacol 431 2001 103 110
15. Y. Raab, C. Sundberg, R. Hallgren, L. Knutson, and B. Gerdin Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis Am J Gastroenterol 90 1995 614 620
16. A.R. Jurjus, N.N. Khoury, and J.M. Reimund Animal models of inflammatory bowel disease J Pharmacol Toxicol 50 2004 81 92
17. K.P. Pavlick, F.S. Laroux, J. Fuseler, R.E. Wolf, L. Gray, and J. Hoffman Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease Free Radic Biol Med 33 2002 311 322
18. J. Pravda Radical induction theory of ulcerative colitis World J Gastroenterol 11 2005 2371 2384
19. A. Banan, J.Z. Fields, Y. Zhang, and A. Keshavarzian iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers Am J Physiol Gastrointest Liver Physiol 280 2001 1234 1246
20. J.W. Bregano, J.B. Dichi, D.S. Barbosa, M.Z. El Kadri, T. Matsuo, and M.A. Rodrigues Decreased total antioxidant capacity in plasma, but not tissue, in experimental colitis Dig Dis Sci 54 2009 751 757
21. A. El-Medany, A. Mahgoub, A. Mustafa, M. Arafa, and M. Morsi The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats Eur J Pharmacol 507 2005 291 299
22. H. Fillmann, N.A. Kretzmann, B. San-Miguel, S. Llesuy, N. Marroni, and J. Gonzalez-Gallego Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat Toxicology 236 2007 217 226
23. I.I. Singer, D.W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W.F. Stenson Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease Gastroenterology 115 1998 297 306
24. E. Kankuri, K. Vaali, R. Korpela, I. Paakkari, H. Vapaatalo, and E. Moilanen Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut Inflammation 25 2001 301 310
25. X.Z. Shi, P.F. Lindholm, and S.K. Sarna NF-κB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells Gastroenterology 124 2003 1369 1380
26. H. Gan, Q. Ouyang, Y. Chen, and Q. Xia Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis Natl Med J China 82 2002 384 388
27. U. Siebenlist, K. Brown, and E. Claudio Control of lymphocyte development by nuclear factor-kappaB Nat Rev Immunol 5 2005 435 445
28. S. Martinez-Florez, B. Gutierrez-Fernandez, S. Sanchez-Campos, J. Gonzalez-Gallego, and M.J. Tunon Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes J Nutr 135 2005 1359 1365
29. M. Sanchez-Hidalgo, A.R. Martin, I. Villegas, and C. Alarcon De La Lastra Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats Biochem Pharmacol 69 2005 1733 1744
30. B. Zingarelli, C. Szabo, and A.L. Salzman Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase Gut 45 1999 199 209
31. R. Di Paola, E. Mazzon, N.S. Patel, T. Genovese, C. Muia, and C. Thiemermann Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid Eur J Pharmacol 507 2005 281 289
32. T. Hibi, N. Inoue, H. Ogata, and M. Naganuma Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease J Gastroenterol 38 2003 36 42